Stockreport

DiaMedica Therapeutics Announces Third Quarter 2019 Financial Results and Provides Business Update

DiaMedica Therapeutics Inc.  (DMAC) 
Last diamedica therapeutics inc. earnings: 11/13 04:12 pm Check Earnings Report
PDF Phase II Study of DM199 in Chronic Kidney Disease Commences ScreeningREMEDY Phase II Study of DM199 in Acute Ischemic Stroke Completes EnrollmentManagement Team Strength [Read more]